日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 在线观看的av | 日韩一区电影 | 精品久久中文字幕 | 波多久久亚洲精品AV无码 | 亚洲综合色婷婷久久 | 成年网站免费观看 | 成人久久久久久久久 | 欧美成人精品二区三区99精品 | 一区二区日韩精品 | 黑人一区 | 黑人插插 | 亚洲www.| 天堂中文网 | 欧美视屏一区二区 | 91av视频在线 | 国内精品伊人久久久影视 | 欧美图片激情小说 | 精品一区二区久久久久久按摩 | 中文字幕av免费 | 欧美综合视频 | 色成人在线 | 国产精品三级在线播放 | 天堂一区二区三区 | 国产精品久久久久不卡 | 久久精品免费视频观看 | 首页亚洲国产丝袜长腿综合 | 国产精品久久久99 | 性高湖久久久久久久久aaaaa | 91精品影视 | 91九色精品国产 | 亚洲欧美日韩另类精品一区二区三区 | 欧美亚洲一区二区三区四区 | 国产毛A片啊久久久久久A | 国产专区精品 | 91成人在线网站 | 在线观看视频一区 | 97视频免费播放观看在线视频 | 日一区二区三区 | 亚洲一区二区三区在线视频 | 污视频在线免费 | 自拍亚洲一区 |